Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyridazines | 2 | 2013 | 16 | 0.430 |
Why?
|
| Menthol | 1 | 2012 | 23 | 0.360 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2012 | 53 | 0.360 |
Why?
|
| Methylcellulose | 1 | 2009 | 7 | 0.310 |
Why?
|
| Isoxazoles | 1 | 2009 | 15 | 0.300 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 182 | 0.300 |
Why?
|
| Sucrose | 1 | 2009 | 33 | 0.300 |
Why?
|
| Anticonvulsants | 1 | 2009 | 40 | 0.300 |
Why?
|
| Nicotine | 1 | 2012 | 302 | 0.290 |
Why?
|
| Drug Compounding | 1 | 2009 | 93 | 0.290 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 241 | 0.280 |
Why?
|
| Zalcitabine | 2 | 1997 | 2 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2013 | 1766 | 0.190 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2013 | 57 | 0.180 |
Why?
|
| Rats | 6 | 2013 | 3735 | 0.160 |
Why?
|
| Dipyridamole | 1 | 1997 | 4 | 0.140 |
Why?
|
| Time Factors | 3 | 2012 | 1857 | 0.140 |
Why?
|
| Nitriles | 2 | 2013 | 81 | 0.100 |
Why?
|
| Pyrimidines | 2 | 2013 | 139 | 0.100 |
Why?
|
| Blood Coagulation | 1 | 2013 | 29 | 0.100 |
Why?
|
| Warfarin | 1 | 2013 | 67 | 0.090 |
Why?
|
| Antipyrine | 1 | 2012 | 4 | 0.090 |
Why?
|
| Radioimmunoassay | 1 | 2012 | 70 | 0.090 |
Why?
|
| Half-Life | 1 | 2012 | 63 | 0.090 |
Why?
|
| Hindlimb Suspension | 1 | 2012 | 16 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2013 | 122 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2012 | 95 | 0.090 |
Why?
|
| Cotinine | 1 | 2012 | 44 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2012 | 92 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 1994 | 195 | 0.090 |
Why?
|
| Animals | 6 | 2013 | 16992 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 146 | 0.080 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 140 | 0.080 |
Why?
|
| Refrigeration | 1 | 2009 | 4 | 0.080 |
Why?
|
| Drug Storage | 1 | 2009 | 28 | 0.080 |
Why?
|
| Suspensions | 1 | 2009 | 48 | 0.070 |
Why?
|
| Drug Stability | 1 | 2009 | 129 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2009 | 260 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 313 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 465 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 2 | 1997 | 30 | 0.060 |
Why?
|
| Male | 5 | 2013 | 23409 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 67 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1997 | 104 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2013 | 30 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 195 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 151 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 1124 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 511 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1028 | 0.020 |
Why?
|
| Female | 1 | 2012 | 24698 | 0.010 |
Why?
|